SavedAdd your journal

Journals / Eurasian Journal of Emergency Medicine / 2014 / Cilt: 13 - Sayı: 3

Diagnostic Significance of Ischemia-Modified Albumin, S100b, and Neuron-Specific Enolase in Acute Ischemic Stroke

Vildan Altunayoğlu ÇAKMAK
Yunus KARACA
Ahmet MENTEŞE
Murat TOPBAŞ
Zekeriya ALİOĞLU
Abdulkadir GÜNDÜZ
Pages
112–117
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Receiver operating characteristics (ROC) curve analysis was used to determine the cut-off values of the biomarker and biomarker groups.Results: Serum IMA, NSE, and S100b levels were significantly higher in ischemic stroke patients (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Use of biochemical markers of cerebral ischemia is a newly favored approach for early diagnosis of ischemic stroke.
📊
Key Findings & Data:Our aim was to establish the sensitivity and specificity of ischemia-modified albumin (IMA) in acute ischemic stroke and to compare it with S100b and neuron-specific enolase (NSE).
💡
Conclusion & Impact:Receiver operating characteristics (ROC) curve analysis was used to determine the cut-off values of the biomarker and biomarker groups.Results: Serum IMA, NSE, and S100b levels were significantly higher in ischemic stroke patients (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Use of biochemical markers of cerebral ischemia is a newly favored approach for early diagnosis of ischemic stroke. Our aim was to establish the sensitivity and specificity of ischemia-modified albumin (IMA) in acute ischemic stroke and to compare it with S100b and neuron-specific enolase (NSE). We also intended to investigate the usefulness of a panel composed of these three biomarkers in acute ischemic stroke.Material and Methods: Consecutive adult patients who were admitted to the emergency department with focal neurological deficits were enrolled. Serum samples were obtained at the initial examination, and IMA, S100b, and NSE were measured. Receiver operating characteristics (ROC) curve analysis was used to determine the cut-off values of the biomarker and biomarker groups.Results: Serum IMA, NSE, and S100b levels were significantly higher in ischemic stroke patients (p

🔖

Cite This Article

ÇAKMAK, V. A., KARACA, Y., MENTEŞE, A., TOPBAŞ, M., ALİOĞLU, Z., GÜNDÜZ, A. (2022). Diagnostic Significance of Ischemia-Modified Albumin, S100b, and Neuron-Specific Enolase in Acute Ischemic Stroke. Eurasian Journal of Emergency Medicine, Cilt: 13 - Sayı: 3, 112–117. https://ajindex.com/articles/508250

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Lansberg MG, Albers GW, Beaulieu C, Marks MP. Comparison of diffusion-weighted MRI and CT in acute stroke. Neurology 2000
  2. [CrossRef] 2. Chalela JA, Kidwell CS, Nentwich LM, Luby M, Butman JA, Demchuk AM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet 2007
  3. [CrossRef] 3. Sotak CH. The role of diffusion tensor imaging in the evaluation of ischemic brain injury - a review. NMR Biomed 2002
  4. [CrossRef] 4. Jauch EC, Lindsell C, Broderick J, Fagan SC, Tilley BC, Levine SR, et all. Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Stroke 2006
  5. [CrossRef] 5. Horstmann S, Kalb P, Koziol J, Gardner H, Wagner S. Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies. Stroke 2003
  6. [CrossRef] 6. Jauch EC, Lindsell C, Broderick J, Fagan SC, Tilley BC, Levine SR
  7. NINDS rt-PA Stroke Study Group. Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Stroke 2006
  8. [CrossRef] 7. Lynch JR, Blessing R, White WD, Grocott HP, Newman MF, Laskowitz DT. Novel diagnostic test for acute stroke. Stroke 2004
  9. [CrossRef] 8. Foerch C, Montaner J, Furie KL, Ning MM, Lo EH: Searching for oracles? Blood biomarkers in acute stroke. Neurology 2009
  10. [CrossRef] 9. Reynolds MA, Kirchick HJ, Dahlen JR, Anderberg JM, McPherson PH, Nakamura KK, et al. Early biomarkers of stroke. Clin Chem 2003
  11. [CrossRef] 10. Abboud H, Labreuche J, Meseguer E, Lavallee PC, Simon O, Olivot JM, et al. Ischemia-modified albumin in acute stroke. Cerebrovasc Dis 2007
  12. [CrossRef] 11. Gunduz A, Turedi S, Mentese A, Altunayoglu V, Turan I, Karahan SC, et al. Ischemia-modified albumin levels in cerebrovascular accidents. Am J Emerg Med 2008
  13. [CrossRef] 12. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993
  14. [CrossRef] 13. Vanni S, Polidori G, Pepe G, Chiarl